文献速递白内障与屈光手术

METTL16通过m6A修饰DKK1介导Wnt/β-catenin信号抑制糖尿病白内障晶状体上皮细胞功能

METTL16 Inhibits Lens Epithelial Cells Function in Diabetic Cataract via m6A-Modified DKK1-Mediated Wnt/β-Catenin Signaling.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本研究探讨METTL16在糖尿病白内障(DC)中的作用,发现DC前囊膜组织和高糖诱导的人晶状体上皮细胞(HLEC)中METTL16表达及m6A甲基化水平升高。MeRIP分析提示DKK1为METTL16靶点,DKK1表达与β-catenin核转位负相关,调控HLEC增殖、迁移和细胞周期。DKK1抑制剂WAY-262611可有效预防高糖诱导的晶状体混浊。

要点

  • DC前囊膜和高糖HLEC中METTL16表达及m6A甲基化水平升高。
  • METTL16通过m6A修饰调控DKK1,DKK1负向调控β-catenin核转位。
  • DKK1抑制剂WAY-262611可预防高糖诱导的晶状体混浊。

核心结论

  • METTL16-DKK1-Wnt/β-catenin轴抑制高糖诱导的HLEC增殖、迁移和细胞周期进展。
  • 该研究为糖尿病白内障的发病机制提供了表观遗传学见解。

研究设计与样本

  • 研究评估了DC前囊膜组织和高糖诱导的HLEC中m6A甲基化水平及METTL16表达。
  • 采用m6A定量和斑点印迹分析、western blot、MeRIP、RNA稳定性实验等探究调控机制。

主要发现

  • DC前囊膜组织和高糖诱导的HLEC中METTL16表达水平和m6A甲基化水平高度升高。
  • MeRIP分析显示DKK1可能通过Wnt/β-catenin通路作为METTL16的靶点。
  • 高糖诱导的HLEC中DKK1表达随METTL16表达增加而升高。
  • DKK1表达与β-catenin核转位负相关,从而调控HLEC增殖、迁移和细胞周期进展。
  • 高糖诱导的晶状体混浊促进白内障形成,DKK1抑制剂WAY-262611治疗有效预防该病理过程。

临床怎么用

  • DKK1抑制剂WAY-262611可能为糖尿病白内障的防治提供潜在策略。
  • METTL16-DKK1-Wnt/β-catenin轴或可作为糖尿病白内障的表观遗传干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To explore the role of methyltransferase-like protein 16 (METTL16), an N6-methyladenosine (m6A) methyltransferase, in the development and progression of diabetic cataracts (DCs), as its underlying molecular mechanisms remain unknown. METHODS: We evaluated m6A methylation levels in total RNA isolated from DC anterior capsule tissue and high glucose (HG)-induced human lens epithelial cells (HLECs) using m6A quantification and dot blot analysis. The expression levels of METTL16 in the anterior capsule tissue were detected using western blot analysis. Methylated RNA immunoprecipitation (MeRIP), RNA stability assays, and other relevant experiments were performed to investigate the regulatory mechanisms of METTL16 on methylation levels in HLECs. Additionally, cellular functions including proliferation, migration, and cell-cycle progression were assessed. RESULTS: The expression level of METTL16 and the level of m6A methylation were highly elevated in the DC anterior capsule tissue and HG-induced HLECs. MeRIP analysis revealed that Dickkopf-1 (DKK1) might act as the target of METTL16 via the Wnt/β-catenin pathway. Notably, the expression of DKK1 increased with the increase in METTL16 expression in HG-induced HLECs. Furthermore, DKK1 expression was negatively correlated with the nuclear translocation of β-catenin, thereby regulating cell proliferation, migration, and cell-cycle progression in HLECs. In addition, HG-induced lens opacity contributes to cataract formation, and treatment with the DKK1 inhibitor WAY-262611 effectively prevented the development of this pathological process. CONCLUSIONS: The METTL16-DKK1-Wnt/β-catenin axis inhibits the proliferation, migration, and cell-cycle progression of HG-induced HLECs. These findings provide an epigenetic insight into the pathogenesis of DC.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Zhang B, Sun Y, Jiang X, et al. METTL16 Inhibits Lens Epithelial Cells Function in Diabetic Cataract via m6A-Modified DKK1-Mediated Wnt/β-Catenin Signaling. Invest Ophthalmol Vis Sci. 2026. PMID: 41533902. doi:10.1167/iovs.67.1.1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。